Unknown

Dataset Information

0

Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.


ABSTRACT:

Aim

To investigate the effects of the natural product Withagulatin A on hepatic stellate cell (HSC) viability and type I procollagen production. The potential mechanism underlying the pharmacological actions was also explored.

Methods

The effect of Withagulatin A on cell viability was evaluated in HSC and LX-2 cells using a sulforhodamine B (SRB) assay. Cell cycle distribution was analyzed using flow cytometry. Type I procollagen gene expression was determined using real-time PCR. Regulation of signaling molecules by Withagulatin A was detected using Western blotting.

Results

Primary rat HSCs and the human hepatic stellate cell line LX-2 treated with Withagulatin A (0.625-20 micromol/L) underwent a dose-dependent decrease in cell viability, which was associated with S phase arrest and the induction of cell apoptosis. In addition, the natural product decreased phosphorylation of the Akt/mTOR/p70S6K pathway that controls cell proliferation and survival. Furthermore, Withagulatin A (1, 2 mumol/L) inhibited transforming growth factor-beta (TGF-beta) stimulated type I procollagen gene expression, which was attributable to the suppression of TGF-beta stimulated Smad2 and Smad3 phosphorylation.

Conclusion

Our results demonstrated that Withagulatin A potently inhibited HSC viability and type I procollagen production, thereby implying that this natural product has potential use in the development of anti-fibrogenic reagents for the treatment of hepatic fibrosis.

SUBMITTER: Liu Q 

PROVIDER: S-EPMC4007817 | biostudies-literature | 2010 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.

Liu Qiong Q   Chen Jing J   Wang Xu X   Yu Liang L   Hu Li-hong LH   Shen Xu X  

Acta pharmacologica Sinica 20100719 8


<h4>Aim</h4>To investigate the effects of the natural product Withagulatin A on hepatic stellate cell (HSC) viability and type I procollagen production. The potential mechanism underlying the pharmacological actions was also explored.<h4>Methods</h4>The effect of Withagulatin A on cell viability was evaluated in HSC and LX-2 cells using a sulforhodamine B (SRB) assay. Cell cycle distribution was analyzed using flow cytometry. Type I procollagen gene expression was determined using real-time PCR.  ...[more]

Similar Datasets

| S-EPMC6273390 | biostudies-literature
| S-EPMC5593560 | biostudies-literature
| S-EPMC7240796 | biostudies-literature
| S-EPMC5192182 | biostudies-literature
| S-EPMC8775563 | biostudies-literature
| S-EPMC11648924 | biostudies-literature
| S-EPMC5666666 | biostudies-other
| S-EPMC8523941 | biostudies-literature
| S-EPMC5696182 | biostudies-literature
| S-EPMC9727849 | biostudies-literature